Comparative Gastrointestinal Blood Loss Associated with Placebo, Aspirin, and Nabumetone as Assessed by Radiochromium (⁵¹Cr)

Non-steroidal anti-inflammatory drugs and serious gastrointestinal adverse reactions--2.

1986 • 134 citations

Preclinical overview of nabumetone

1987 • 49 citations

Correlation between gastric irritancy and anti-inflammatory activity of non-steroidal anti-inflammatory drugs

1984 • 41 citations

Endoscopy-controlled study of the safety of nabumetone compared with naproxen in arthritis therapy

1987 • 33 citations

Endoscopic studies of nabumetone in patients with rheumatoid arthritis

1987 • 31 citations

Radiochromium (chromium-51) evaluation of gastrointestinal blood loss associated with placebo, aspirin, and nabumetone

1987 • 28 citations

Six-month multi-center study comparing nabumetone with naproxen in the treatment of osteoarthritis

1987 • 23 citations

Safety evaluation of nabumetone in United States clinical trials

1987 • 20 citations

Gastrointestinal Blood Loss of Oxaprozin and Aspirin with Placebo Control

1982 • 18 citations

Review of the experience with nabumetone in clinical trials outside of the United States

1987 • 17 citations

Long-term treatment of rheumatoid arthritis comparing nabumetone with aspirin

1987 • 16 citations

Effect of Naproxen on Gastrointestinal Microbleeding Following Acetylsalicylate Medication

1975 • 15 citations

The use of a 51Cr technique to detect gastrointestinal microbleeding associated with nonsteroidal antiinflammatory drugs

1988 • 12 citations

Gastrointestinal microbleeding in normal subjects receiving acetylsalicylic acid, placebo, and R-803, a new antiinflammatory agent, in a design balanced for residual effects.

1976 • 7 citations

Gastrointestinal blood loss induced by ketoprofen, aspirin and placebo (preliminary report).

1976 • 6 citations